Nitinol Devices & Components acquires Interface Catheter Solutions to create Confluent Medical Technologies


Nitinol Devices & Components (NDC) has successfully completed the acquisition of Interface Catheter Solutions. The two companies will create Confluent Medical Technologies.

A press release says that the combined company will leverage the technical expertise of both NDC and Interface in highly precise and demanding medical devices. Additionally, the complementary technology platforms create a unique opportunity to deepen relationships with the existing customer base, particularly in the endovascular, neurovascular, transcatheter heart valve, peripheral vascular, ENT and orthopaedic markets.

Interface is the contract manufacturer of balloon catheter systems. The company combines best-in-class balloon design and development, high-quality balloon contract manufacturing and deep equipment manufacturing expertise to serve a broad array of medical device customers. Interface specialises in ultra-high-pressure, high-pressure, textured surface and jumbo balloons in addition to full balloon catheter assemblies. The company’s optimised extrusion capabilities, supporting balloon contract manufacturing, produces quality and reliable extrusions.

The combination represents a significant step forward in providing fully integrated solutions to medical device customers. Confluent Medical’s portfolio of services includes:

  • Nitinol component contract manufacturing
  • Balloon component contract manufacturing
  • Balloon catheter assembly contract manufacturing
  • Nitinol core guidewire contract manufacturing
  • Nitinol device design and testing services
  • Balloon catheter design and testing services
  • Balloon manufacturing equipment
  • Nitinol material
  • Extrusion

“The acquisition of Interface reflects our commitment to investing in material science technologies that enable us to best serve the medical device community,” said Dean Schauer, NDC president and chief executive officer. “The NDC-Interface combination is an excellent strategic fit and we are excited to leverage the key talent and technical expertise of the combined companies to provide world class, differentiated products to our customers.”

Tom Duerig, chief technology officer, commented, “It has long been a goal of NDC to apply its manufacturing, quality systems and technical expertise beyond Nitinol, broadening the manufacturing and outsourcing solutions we can offer to customers. The exceptional technical strength of Interface with polymers, catheters and balloons provides the perfect opportunity to accomplish just that.”